scholarly article | Q13442814 |
P2093 | author name string | Matsushima K | |
Oppenheim JJ | |||
Akahoshi T | |||
P2860 | cites work | The effect of ACTH and cortisone on the concentration of circulating diphtheria antitoxin. | Q51041459 |
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). | Q53545542 | ||
Effect of hydrocortisone on the reactivity of thymus and spleen cells of mice to in vitro stimulation | Q54255776 | ||
Glucocorticoid receptors in rat thymocytes. Interactions with the antiglucocorticoid cortexolone and mechanism of its action. | Q54688881 | ||
Interleukin 1: a regulatory role in glucocorticoid-regulated hepatic metabolism | Q68800403 | ||
Effect of Prednisone Treatment on the Human Immune Response to Keyhole Limpet Hemocyanin | Q69373802 | ||
Effect of hydrocortisone on immunoglobulin synthesis and secretion by human peripheral lymphocytes in vitro | Q69384226 | ||
Corticotropin-releasing activity of monokines | Q70107751 | ||
Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression | Q70140429 | ||
Mechanism of glucocorticoid-induced increase in insulin receptors of cultured human lymphocytes | Q70239884 | ||
Corticosteroids and Lymphoid Cells | Q70417968 | ||
Corticosteroid alteration of human monocyte to macrophage differentiation | Q70430514 | ||
Interleukin 1, a potential regulator of fibroblast proliferation | Q70566329 | ||
Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells | Q70586035 | ||
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens | Q71005962 | ||
Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production | Q71620199 | ||
Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages | Q72074417 | ||
The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen | Q72785423 | ||
Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein | Q72788112 | ||
Inhibition of human leukocyte mitosis by prednisolone in vitro | Q79034776 | ||
Potentiation of the T-lymphocyte response to mitogens. I. The responding cell | Q24679275 | ||
Glucocorticoid regulation of ACTH sensitivity of adenyl cyclase in rat fat cell membranes | Q33701040 | ||
Characterization of a human blood monocyte subset with low peroxidase activity | Q33822380 | ||
Glucocorticosteroid therapy: mechanisms of action and clinical considerations | Q34058573 | ||
The Effect of In Vivo Hydrocortisone on Subpopulations of Human Lymphocytes | Q34460078 | ||
Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone | Q34511999 | ||
Detection of a mediator derived from endotoxin-stimulated macrohpages that induces the acute phase serum amyloid A response in mice | Q36342798 | ||
Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation | Q36347822 | ||
Lymphokine-activated killer cells. Analysis of progenitors and effectors | Q36352956 | ||
Immunoglobulin production induced in vitro by glucocorticoid hormones: T cell-dependent stimulation of immunoglobulin production without B cell proliferation in cultures of human peripheral blood lymphocytes | Q37006599 | ||
Dexamethasone modulates binding and action of epidermal growth factor in serum-free cell culture | Q37583971 | ||
Suppression of the human autologous mixed lymphocyte reaction by physiologic concentrations of hydrocortisone | Q39444993 | ||
Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation | Q40721133 | ||
Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation | Q40790308 | ||
Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1. | Q40838264 | ||
Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta. | Q41366245 | ||
The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay | Q42015670 | ||
Glucocorticoids increase cholecystokinin receptors and amylase secretion in pancreatic acinar AR42J cells. | Q42486585 | ||
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. | Q42937489 | ||
Phosphorylation of a cytosolic 65-kDa protein induced by interleukin 1 in glucocorticoid pretreated normal human peripheral blood mononuclear leukocytes | Q44162774 | ||
Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids | Q46720816 | ||
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity | Q46759229 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lymphocyte | Q715347 |
P304 | page(s) | 924-936 | |
P577 | publication date | 1988-03-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Induction of high-affinity interleukin 1 receptor on human peripheral blood lymphocytes by glucocorticoid hormones | |
P478 | volume | 167 |
Q41718323 | A soluble form of the interleukin-1 receptor produced by a human B cell line |
Q44093166 | Annexin 1 (lipocortin 1) mimics inhibitory effects of glucocorticoids on testosterone secretion and enhances effects of interleukin-1beta |
Q37745385 | Beta-endorphin: cytokine and neuropeptide |
Q40724199 | Biology of interleukin-1 (IL-1), with respect to otorhinolaryngology-head and neck surgery |
Q69736584 | Characteristics of human synovial fibroblast activation by IL-1 beta and TNF alpha |
Q42554565 | Circadian characteristics of permissive and suppressive effects of cortisol and their role in homeostasis and the acute inflammatory response. |
Q37803475 | Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system |
Q38302879 | Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes |
Q38219284 | Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus |
Q45748847 | Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination |
Q72463088 | Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes |
Q44077624 | Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells |
Q44392409 | Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens. |
Q41133430 | Effects of antirheumatic agents on cytokines |
Q53023352 | Effects of methylprednisolone on the energy metabolism of quiescent and conA-stimulated thymocytes of the rat |
Q30484097 | Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology |
Q24558719 | Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells |
Q41667038 | Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line |
Q40722344 | Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases. |
Q73085678 | Glucocorticoids enhance concanavalin A-induced mitogenic response through the inhibition of nitric oxide production |
Q42769403 | Glucocorticoids induce the expression of CD8 alpha chains on concanavalin A-activated rat CD4+ T cells: induction is inhibited by rat recombinant interleukin 4 |
Q68258339 | Glucocorticoids upregulate the high affinity receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes in vitro |
Q52243932 | Hematopoietic growth factor receptors. |
Q41850412 | Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. |
Q57781165 | In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression |
Q77324786 | Induction of cytokine receptors by glucocorticoids: functional and pathological significance |
Q35591162 | Interleukin 1 stimulates its own receptor expression on human fibroblasts through the endogenous production of prostaglandin(s). |
Q35232151 | Interleukin-1 receptor mRNA expression in activated bovine leukocytes in vitro |
Q40572399 | Interleukin-1 receptors in brain and pituitary. Characterization and modulation during infection and stress |
Q41627636 | Interleukin‐1 up‐regulates transcription of its own receptor in a human fibroblast cell line TIG‐1: role of endogenous PGE2 and cAMP |
Q35530019 | Isolation and characterization of glucocorticoid- and cyclic AMP-induced genes in T lymphocytes |
Q71541318 | Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus |
Q53981432 | Modulation of tumor necrosis factor (TNF) receptor expression during monocytic differentiation by glucocorticoids. |
Q28319970 | Molecular analysis of the inhibition of interleukin-8 production by dexamethasone in a human fibrosarcoma cell line |
Q41639445 | Regulation of interleukin‐1 receptors on AtT‐20 mouse pituitary tumour cells |
Q43874547 | Relationship between interleukin 1 (IL1), tumor necrosis factor (TNF) and a neutrophil attracting peptide (NAP-1). |
Q67700876 | Retinoic acid potentiates interleukin-1- and fibroblast growth factor-induced human synovial fibroblast proliferation |
Q48774229 | Role of corticosterone in the behavioral effects of central interleukin-1 beta |
Q38208984 | The CD5 B cell |
Q40378976 | The immune system and integrated homeostasis |
Q24680185 | The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor |
Q33406063 | Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I. |
Q35236513 | Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis |